• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of March 20, 2013

  • Print
  • Share
  • E-mail
-

Event Detail

Event ID 52256
Product Type Biologics
Status Terminated
Recalling Firm American National Red Cross (The)
City Portland
State OR
Country US
Voluntary/Mandated Voluntary: Firm Initiated
Recall Initiation Date 2009-02-12
Initial Firm Notification of
Consignee or Public
FAX
Distribution Pattern Medical Centers nationwide

Product Detail

Product Description Code Info Classification Reason for Recall Product Quantity Recall Number
Red Blood Cells Leukocytes Reduced 21KS81850; 21KS81876; 21KS81897; 21KS81923; 21KS81935; 21KS81947; 21KS82044; 21KS82070; 21KS82103; 21KS82123; 21KS82126; 21KS82133; 21KS82142; 21KS82158; 21KS82159; 21KS82162; 21KS82165; 21KS82343; 21KS82344; 21KS82485; 21KS82487; 21KY24230; 21KY24248; 21LG75833; 21LG75842; 21LG75852; 21LG75874; 21LG75890; 21LG75920; 21LG75931; 21LG75963; 21LG75981; 21LG75982; 21LK55444; 21LK55449; 21LK55473; 21LL53586; 21LL53593; 21LL53597; 21LL53612; 21LL53616; 21LL54081; 21LL54095; 21LS04243; 21LS04244. Class II Blood products, possibility sterility compromised and contaminated, were distributed. 45 units B-0627-13
Red Blood Cells 21KS82405; 21KS82409 Class II Blood products, possibility sterility compromised and contaminated, were distributed. 2 units B-0628-13
Red Blood Cells Leukocytes Reduced Irradiated 21KY24238; 21LH71621. Class II Blood products, possibility sterility compromised and contaminated, were distributed. 2 units B-0629-13
Cryoprecipitated AHF 21KS81143; 21KS81153; 21KS81169; 21KS81174; 21KS81177; 21KS81182; 21KS81406; 21KS81409; 21KS81418; 21KS81426; 21KS81876; 21KS81897; 21KS81923; 21KS81935; 21KS82044; 21KS82103; 21KS82123; 21KS82126; 21KS82133; 21KS82318; 21KS82343; 21KS82344; 21KY24230; 21KY24234; 21KY24238; 21KY24248; 21LG74950; 21LG75874; 21LG75890; 21LG75963; 21LG75981; 21LG75982; 21LH70417; 21LH70423; 21LH70426; 21LH70436; 21LH70451; 21LH70454; 21LH70460; 21LH70462; 21LH70468; 21LH70478; 21LL51972; 21LL52214, 21LL52547; 21LL53593; 21LL53597. Class II Blood products, possibility sterility compromised and contaminated, were distributed. 47 units B-0630-13
Plasma Frozen 21KS82070; 21KS82165; 21KS82485; 21KS82487; 21KW70562; 21KW70564; 21KW70567; 21KW70568; 21KW70571; 21KW70579; 21KY23565; 21KY23579; 21KY23581; 21KY23590; 21KY23592; 21KY23602; 21LG75833; 21LG75852; 21LG75961; 21LH70618; 21LH70637; 21LH70642; 21LH70644; 21LL53612. Class II Blood products, possibility sterility compromised and contaminated, were distributed. 24 units B-0631-13
Plasma Frozen Cryoprecipitate Reduced 21KS81418; 21KS81426; 21KY24230; 21LG75006; 21LH70417; 21LH70426; 21LL51972; 21LL52533; 21LL52547. Class II Blood products, possibility sterility compromised and contaminated, were distributed. 9 units B-0632-13
-
-